Carbon C 14 eribulin acetate
Term · Oncology and biomedicine · MLC-T-ONC-012272
A radioconjugate containing the acetate salt of eribulin, labeled with the beta particle-emitting radioisotope carbon C 14, with radioisotopic and potential antineoplastic activities. Upon administration, eribulin binds to the vinca domain of tubulin and inhibits the polymerization of tubulin and the assembly of microtubules, resulting in inhibition of mitotic spindle assembly, induction of cell cycle arrest at G2/M phase, and, potentially, tumor regression. The radioisotope moiety of this agent acts as a radioactive tracer.
| Identifier | MLC-T-ONC-012272 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | 14C-eribulin acetate |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012272",
"term": "Carbon C 14 eribulin acetate",
"field": "Oncology and biomedicine",
"definition": "A radioconjugate containing the acetate salt of eribulin, labeled with the beta particle-emitting radioisotope carbon C 14, with radioisotopic and potential antineoplastic activities. Upon administration, eribulin binds to the vinca domain of tubulin and inhibits the polymerization of tubulin and the assembly of microtubules, resulting in inhibition of mitotic spindle assembly, induction of cell cycle arrest at G2/M phase, and, potentially, tumor regression. The radioisotope moiety of this agent acts as a radioactive tracer.",
"synonyms": [
"14C-eribulin acetate"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/carbon-c-14-eribulin-acetate/"
}
Record 4,175 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.